Featured News

The Celiac Disease Foundation is proud to partner with Mediaplanet for their Morning Nutrition campaign.

The Foundation is pleased to announce its partnership with Provention Bio to provide clinical trial recruitment for its Phase 2b PROACTIVE Celiac Study for PRV-015 (an anti-interleukin-15 monoclonal antibody).

A new study from Columbia University is the first to follow the trail for many years and show that people diagnosed with celiac disease in childhood are more likely to experience psychological conditions well into adulthood.

Securing public and private health insurance coverage of Medical Nutrition Therapy (MNT) for celiac disease patients has been a long-time priority of the Celiac Disease Foundation.

The Celiac Disease Foundation through the generosity of Proud Sponsor Schar is providing reimbursement grants to dietitians who complete all five COT modules.

Dr. Samuel Gee was the first researcher to recognize that the symptoms of celiac disease could be treated through diet. Today, we celebrate Celiac Disease Awareness Day on Dr. Gee's birthday and remember how far we've come in celiac disease knowledge and research, while recognizing there is still a critical need for treatments and a cure.

The CDF Turkey Trot raises funds to support celiac disease research. This year we are going virtual with a Cross-Country Challenge on Saturday, November 14 and Sunday, November 15.

Today, the U.S. Food and Drug Administration issued a final rule for gluten-free labeling compliance requirements for fermented and hydrolyzed foods.

I want to share with you an update of our work in Washington, DC with Congress and NIH to accelerate research for diagnostics, treatments, and a cure for celiac disease.

The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.